GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,915,000 | +198.3% | 28,111 | +39.9% | 0.01% | +150.0% |
| Q2 2022 | $642,000 | +191.8% | 20,097 | +132.9% | 0.00% | +100.0% |
| Q3 2021 | $220,000 | -23.3% | 8,630 | +5.4% | 0.00% | 0.0% |
| Q2 2021 | $287,000 | -13.8% | 8,189 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $333,000 | -6.7% | 8,168 | -0.9% | 0.00% | 0.0% |
| Q4 2020 | $357,000 | -23.1% | 8,243 | -2.0% | 0.00% | -50.0% |
| Q3 2020 | $464,000 | -5.7% | 8,415 | +8.0% | 0.00% | -33.3% |
| Q2 2020 | $492,000 | +10.1% | 7,793 | -11.0% | 0.00% | 0.0% |
| Q1 2020 | $447,000 | -58.7% | 8,754 | -63.4% | 0.00% | -80.0% |
| Q2 2018 | $1,082,000 | +116.8% | 23,939 | +48.9% | 0.02% | +66.7% |
| Q3 2017 | $499,000 | – | 16,082 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |